Skip to main content
SpringerLink
Log in

Effect and safety of Tripterygium Hypoglaucum (Lévl.) hutch in treating proteinuria of kidney transplant recipients

  • Clinical Experience
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate the therapeutic and adverse effects of Tripterygium hypoglaucum (Lévl.) Hutch (THH) in treating proteinuria of renal transplant recipients.

Methods

Thirty patients with proteinuria greater than 1 g/24 h were enrolled to be treated with one tablet preparation of THH extract (360 mg, 3 times daily, equivalent to triptolide 30 μg/d) for 6 months. The proteinuria, serum creatinine, sex hormones, semen analysis and erectile function in male were determined at entry, 3 and 6 months. Incidence of adverse events was evaluated.

Results

THH treatment significantly improved proteinuria (from 2.52±1.87 g/d at baseline to 1.11±0.96 g/d at 3 months, and to 1.04±1.09 g/d at 6 months). No significant changes were observed in serum creatinine, liver enzymes or complete blood count. In female (15 cases), THH treatment induced a significant increase in follicle stimulating hormone and luteinizing hormone levels, and a significant decrease in estradiol and progesterone levels, and the main adverse effects were reversible menstrual irregularities (73.3% at 6 months). In male (15 cases), the sperm concentration and viability were markedly decreased by THH treatment, but the sex hormone levels and erectile function did not change significantly by treatment.

Conclusions

THH is effective and safe for the treatment of proteinuria in renal transplant recipients. Its primary adverse effect is reversible toxicity to reproductive organs. Further controlled clinical trials are warranted to determine the true clinical benefit of THH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007;7:2748–2756.

    Article  CAS  PubMed  Google Scholar 

  2. Roodnat JI, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T, Zietse R, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001;72:438–444.

    Article  CAS  PubMed  Google Scholar 

  3. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004;65:2309–2320.

    Article  PubMed  Google Scholar 

  4. Ruggenenti P, Perna A, Remuzzi G. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 2003;63:2254–2261.

    Article  CAS  PubMed  Google Scholar 

  5. Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007;7:2350–2360.

    Article  CAS  PubMed  Google Scholar 

  6. Brinker AM, Ma J, Lipsky PE, Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007;68:732–766.

    Article  CAS  PubMed  Google Scholar 

  7. Lin LM, Qi XM. Comparative observation on the effects of Radix tripterygium hypoglaucum tablet and Tripterygium glycosides tablet in treating erosive oral lichen planus. Chin J Integr Med 2005;11:149–150.

    Article  PubMed  Google Scholar 

  8. Teng LC, Wang CX, Chen L. Improved erectile function and sex hormone profi les in male Chinese recipients of kidney transplantation. Clin Transplant 2011;25:265–269.

    Article  CAS  PubMed  Google Scholar 

  9. Li S, Wang X. HPLC determination of triptolide in Kunming Shanghaitang tablets. Chin J Pharm Anal (Chin) 2008;28:1150–1152.

    Google Scholar 

  10. Li SY, Zhang C, He L, Nong X. The clinical use of Tripterygium hypoglaucum (Lévl.) Hutch. Chin J Ethnomed (Chin) 2006;15:325–330.

    Google Scholar 

  11. Hu SH, Pi XM, Li H. A combination oral therapy with fibraurea stem tablet and dapsone in treatment of 64 cases with posriasis valgrais. Chin J Derm Venereol (Chin) 2004;18:34.

    Google Scholar 

  12. Wang YM, Pan H. Report of fibraurea stem tablet in the treatment of 120 cases with corticosteroid dependent dermatitis. Chin J Derm Venereol (Chin) 2002;16:314–315.

    Google Scholar 

  13. Fujita R, Duan H, Takaishi Y. Terpenoids from Tripterigyum hypoglaucum. Phytochemistry 2000;53:715–722.

    Article  CAS  PubMed  Google Scholar 

  14. Qian SZ, Hu YZ, Wang SM, Luo Y, Tang AS, Shu SY, et al. Effects of Tripterygium hypoglaucum (Levl.) Hutch on male fertility. Adv Contracept 1988;4:307–310.

    Article  CAS  PubMed  Google Scholar 

  15. Zhou JW, Pan RN, Liu LW, Peng L, Luo Y, Zhang XM, et al. Preliminary studies on Tripteryguim hypoglaucum (Levl.) Hutch inhibition on fertility in rat. Med Pharm Yunnan (Chin) 1991;14:232–235.

    Google Scholar 

  16. Gu WZ, Chen R, Brandwein S, McAlpine J, Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int J Immunopharmacol 1995;17:351–356.

    Article  CAS  PubMed  Google Scholar 

  17. Ma J, Dey M, Yang H, Poulev A, Pouleva R, Dorn R, et al. Anti-infl ammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 2007;68:1172–1178.

    Article  CAS  PubMed  Google Scholar 

  18. Tao X, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F. J Pharmacol Exp Ther 1995;272:1305–1312.

    CAS  PubMed  Google Scholar 

  19. Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Kidney Int 2008;74:596–612.

    Article  CAS  PubMed  Google Scholar 

  20. Chen ZH, Qin WS, Zeng CH, Zheng CX, Hong YM, Lu YZ, et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 2010;77:974–988.

    Article  CAS  PubMed  Google Scholar 

  21. Liu J, Jiang Z, Liu L, Zhang Y, Zhang S, Xiao J, et al. Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats. Drug Chem Toxicol 2011;34:1–7.

    Article  PubMed  Google Scholar 

  22. Ni B, Jiang Z, Huang X, Xu F, Zhang R, Zhang Z, et al. Male reproductive toxicity and toxicokinetics of triptolide in rats. Arzneimittelforschung 2008;58:673–680.

    CAS  PubMed  Google Scholar 

  23. Kitzen JJ, de Jonge MJ, Lamers CH, Eskens FA, van der Biessen D, van Doorn L, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours. Eur J Cancer 2009;45:1764–1772.

    Article  CAS  PubMed  Google Scholar 

  24. Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002;8:2666–2674.

    CAS  PubMed  Google Scholar 

  25. Dudley C, Pohanka E, Riad H, Dedochova J, Wijngaard P, Sutter C, et al. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the “creeping creatinine” study. Transplantation 2005;79:466–475.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Organ Transplantation, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510700, China

    Xiao-peng Yuan  (袁小鹏), Qian Fu  (傅 茜) & Chang-xi Wang  (王长希)

Authors
  1. Xiao-peng Yuan  (袁小鹏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qian Fu  (傅 茜)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chang-xi Wang  (王长希)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-peng Yuan  (袁小鹏).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuan, Xp., Fu, Q. & Wang, Cx. Effect and safety of Tripterygium Hypoglaucum (Lévl.) hutch in treating proteinuria of kidney transplant recipients. Chin. J. Integr. Med. (2014). https://doi.org/10.1007/s11655-014-1688-7

Download citation

  • Received:

  • Published:

  • DOI: https://doi.org/10.1007/s11655-014-1688-7

Keywords

Search

Navigation